Leerink Partners Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Market Perform

March 11, 2024 6:07 AM EDT Send to a Friend
(Updated - March 11, 2024 8:49 AM EDT)

Leerink Partners analyst Marc Goodman downgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login